Morbidity and Mortality After Stroke—Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES) | Zendy

AI Assistant Blog Pricing

Morbidity and Mortality After Stroke—Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.